Seasonal Depression: Why Fall and Winter Hit Some People Hard
Seasonal affective disorder is not simply “winter sadness.” It is a recurrent form of major depression with a predictable seasonal pattern, specific neurobiological drivers, and evidence-based treatments that work best when started early.
Quick answer
Seasonal affective disorder (SAD) is a recurrent pattern of major depressive episodes occurring in fall and winter with remission in spring, driven by reduced light exposure that disrupts circadian rhythms and melatonin regulation. First-line treatments — light therapy, bupropion XL prophylaxis, and antidepressants — are most effective when started in early fall before the episode fully establishes.

What Seasonal Affective Disorder Actually Is
Seasonal affective disorder is not a separate diagnosis but a specifier for major depressive disorder or bipolar disorder: specifically, a pattern of mood episodes that consistently occur at a particular time of year and fully remit at another. The most common pattern is fall-winter onset with spring remission, though a less common summer-onset pattern exists.
To meet criteria for the seasonal pattern specifier, the seasonal relationship must have occurred over at least two consecutive years, with full remission between episodes. The seasonal episodes must substantially outnumber any non-seasonal depressive episodes over the person’s lifetime. This distinguishes SAD from ordinary depression that happens to worsen in winter from identifiable situational stressors.
The clinical presentation of fall-winter SAD has characteristic features that distinguish it from non-seasonal depression. Unlike the appetite loss and insomnia that typify melancholic depression, SAD typically involves increased sleep (hypersomnia), increased appetite with carbohydrate cravings, fatigue, and social withdrawal — a pattern sometimes called “atypical” or “vegetative” depression. This profile reflects the hibernation-like biological response to reduced light that the seasonal depression mechanism produces.
SAD affects approximately 1–6% of the population, with significantly higher rates in populations living at higher latitudes and lower rates near the equator. East Texas, while not at high latitude, has enough seasonal variation in day length to produce the light exposure changes that drive SAD in susceptible individuals — particularly in overcast fall and winter conditions that reduce light even during daylight hours.
The Neurobiological Mechanism
The mechanisms of SAD involve reduced light exposure acting on the circadian timing system and the monoaminergic neurotransmitter systems that regulate mood, sleep, and appetite.
Circadian disruption. Light is the primary zeitgeber — the environmental time cue that entrains the circadian clock in the suprachiasmatic nucleus (SCN) of the hypothalamus. Reduced light exposure in fall and winter delays and disrupts the circadian phase, producing a mismatch between the internal biological clock and the external light-dark cycle. This circadian disruption is one of the primary mechanisms by which seasonal light changes produce mood, sleep, and energy disturbances in SAD.
Melatonin dysregulation. Melatonin, produced by the pineal gland during darkness, is suppressed by light exposure. In SAD patients, the duration of melatonin secretion extends as nights lengthen in fall and winter — a longer biological night signal that corresponds to the vegetative, withdrawal-like features of the seasonal depressive episode. Phase-shifting melatonin secretion with morning light exposure is one mechanism by which light therapy produces its antidepressant effect.
Serotonergic dysfunction. SAD patients show increased serotonin transporter activity in fall and winter, leading to reduced synaptic serotonin availability during the seasonal episode. This is the same mechanism that conventional antidepressants (SSRIs) address, which explains why SSRIs are effective for SAD. Light therapy also appears to increase serotonin availability through direct effects on serotonin synthesis.
Dopaminergic effects. Reduced dopaminergic activity in winter contributes to the anhedonia, fatigue, and carbohydrate craving of SAD. The dopaminergic reward system responds to light exposure, which is one reason light therapy produces rapid improvement in energy and mood compared to the slower effect of antidepressants on this system.

Evidence-Based Treatments
Light therapy is the first-line evidence-based treatment for seasonal affective disorder and the most specific to its mechanism. A 10,000-lux white light box used for 20–30 minutes in the morning within the first hour of waking produces phase-shifting and serotonergic effects that address the core SAD mechanism. Multiple RCTs demonstrate that light therapy is as effective as SSRIs for SAD, with faster onset of action (days rather than weeks). It is most effective when started in early fall — September or October — before the full depressive episode is established.
Light box selection matters: 10,000 lux white fluorescent light (not UV, not dim, not colored) in a box positioned at eye level approximately 18–24 inches away during morning activities is the standard protocol. Timing is important: morning use is significantly more effective than evening use for fall-winter SAD because of its phase-advancing effect on circadian timing.
Bupropion XL is the only antidepressant with FDA approval specifically for SAD prophylaxis. Started in September before the anticipated seasonal onset and continued through spring, it significantly reduces SAD episode severity and frequency. For patients with two or more prior seasonal episodes, prophylactic bupropion is a strong clinical option alongside or instead of light therapy.
SSRIs and SNRIs are effective for SAD treatment when the episode has established. They work through serotonergic mechanisms consistent with the SAD mechanism, though their onset is slower than light therapy. For moderate to severe seasonal depression already established, combined light therapy and antidepressant treatment produces better outcomes than either alone.
ETX Psychiatry evaluates and treats seasonal depression. Call (430) 288-5800 or schedule online. We accept Medicare, Aetna, BCBS, Cigna, Optum, UHC, UMR, and Ambetter. 100 Independence Pl, Suite 405, Tyler, TX 75703. Telehealth available.

Early Intervention: Why September and October Matter
The most important clinical message about SAD treatment is timing. Most people with SAD begin treatment reactively — after the episode is fully established, typically in December or January when functioning is already significantly impaired. Early intervention in September or October, before the episode reaches full severity, consistently produces better outcomes than waiting.
Light therapy started in early fall can prevent or significantly attenuate the episode before it fully develops. Bupropion XL prophylaxis started in September produces significantly better seasonal episode prevention than starting it after symptoms are already severe. The window between first noticing early mood changes in September and full episode establishment in November or December is the most clinically productive intervention window for SAD.
Patients who have had prior seasonal episodes have the clearest clinical indication for proactive fall treatment: the prior pattern predicts future pattern with high reliability, and early intervention based on established pattern is medically appropriate without waiting for full symptom recurrence.
ETX Psychiatry serves Tyler, Longview, Lufkin, Nacogdoches, and East Texas patients via telehealth. If your mood consistently worsens in fall and winter, that pattern is worth a clinical conversation. Call (430) 288-5800.
Key Takeaways
- Seasonal affective disorder is recurrent major depression with a consistent fall-winter pattern, not simply winter sadness or holiday stress
- SAD involves circadian disruption, melatonin dysregulation, and reduced serotonin availability — all driven by reduced light exposure
- Light therapy (10,000 lux, 20–30 minutes each morning) is first-line treatment and most effective when started in early fall before the full episode
- Bupropion XL is the only FDA-approved antidepressant for SAD prophylaxis and is most effective when started in September before the seasonal onset
- Early intervention in September or October consistently produces better outcomes than reactive treatment after the episode is fully established
Frequently Asked Questions
Is seasonal depression a real diagnosis?
Yes. Seasonal affective disorder is a recognized specifier for major depressive disorder in the DSM-5, requiring a consistent seasonal pattern of depressive episodes occurring over at least two years with full remission between episodes. It is not simply feeling down in winter — it is a clinically significant depressive condition with specific neurobiological drivers.
Does East Texas get enough seasonal variation to cause SAD?
Yes. While East Texas is not at high latitude, the seasonal reduction in day length and the increase in overcast weather in fall and winter produce enough reduction in light exposure to trigger SAD in susceptible individuals. Susceptibility is determined by individual circadian and serotonergic sensitivity, not only by latitude.
How do I know if I have SAD or just regular depression?
The key distinguishing feature is a consistent seasonal pattern: episodes that reliably begin in fall or winter and remit in spring, over at least two consecutive years. The symptom profile also differs: SAD typically involves hypersomnia and increased appetite rather than the insomnia and appetite loss of non-seasonal melancholic depression.
What light box should I buy?
A 10,000-lux white fluorescent light box with UV filtering, positioned at eye level approximately 18–24 inches away during morning activities. Commercially available boxes from companies like Carex, Verilux, and Northern Light Technologies meet these specifications. Avoid UV-emitting lights and low-lux devices marketed for SAD that do not reach the therapeutic threshold.
How quickly does light therapy work?
Many patients notice improvement in energy and mood within the first week of consistent light therapy. This is significantly faster than the 4–8 weeks required for antidepressant medication response. Early improvement is one reason light therapy is preferred as first-line SAD treatment.
Can I do light therapy if I take medications that cause photosensitivity?
Some medications increase photosensitivity — certain antibiotics, antipsychotics, and others. Discuss light therapy with your prescribing provider if you take photosensitizing medications. UV-filtering light boxes reduce (though do not eliminate) photosensitivity risk.
Does vitamin D help with seasonal depression?
Vitamin D deficiency is more common in winter and correlates with mood, but supplementation studies do not show consistent antidepressant effects for SAD specifically. Vitamin D is worth monitoring and treating if deficient for overall health, but it is not a substitute for light therapy or antidepressant treatment for clinical seasonal depression.
What if my SAD does not respond to light therapy?
Inadequate response to light therapy alone is an indication for adding an antidepressant (SSRIs, SNRIs, or bupropion XL) or reviewing whether the light therapy protocol is being followed correctly. Some patients with severe SAD require combined treatment. A psychiatric evaluation clarifies the treatment plan and rules out non-seasonal depression that overlaps seasonally.